Autosomal Dominant Polycystic Kidney Disease Latest Advances

Find the Latest Research About Autosomal Dominant Polycystic Kidney Disease

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5901 publications

Zebrafish as a Model System for Polycystic Kidney Disease: Lessons from ift140 Mutants.

Zebrafish as a Model System for Polycystic Kidney Disease: Lessons from ift140 Mutants.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 22, 2026

Author's Reply: Unrecognized Biases and Validation Gaps in TraceOrg for Automated Autosomal Dominant Polycystic Kidney Disease Volumetry.

Author's Reply: Unrecognized Biases and Validation Gaps in TraceOrg for Automated Autosomal Dominant Polycystic Kidney Disease Volumetry.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 21, 2026

Correction to: Kidney Week 2025 Abstract Three-Month Interim Analysis of Ketogenic Metabolic Therapy in Japanese Patients with ADPKD SA-PO0579.

Correction to: Kidney Week 2025 Abstract Three-Month Interim Analysis of Ketogenic Metabolic Therapy in Japanese Patients with ADPKD SA-PO0579.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 21, 2026

Correction to: Kidney Week 2025 Abstract Artificial Intelligence in Autosomal Dominant Polycystic Kidney Disease: Transforming Diagnosis, Risk Stratification, and Therapeutic Interventions SA-PO0555.

Correction to: Kidney Week 2025 Abstract Artificial Intelligence in Autosomal Dominant Polycystic Kidney Disease: Transforming Diagnosis, Risk Stratification, and Therapeutic Interventions SA-PO0555.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 21, 2026

Unrecognized Biases and Validation Gaps in TraceOrg for Automated Autosomal Dominant Polycystic Kidney Disease Volumetry.

Unrecognized Biases and Validation Gaps in TraceOrg for Automated Autosomal Dominant Polycystic Kidney Disease Volumetry.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 21, 2026

Targeting Ogt in ADPKD mitigates metabolic reprogramming and renal cystogenesis, extending survival.

Targeting Ogt in ADPKD mitigates metabolic reprogramming and renal cystogenesis, extending survival.

Journal: bioRxiv : the preprint server for biology
Published: December 25, 2025

The Relationship of Renalase with Diurnal Blood Pressure Rhythm, Left Ventricular Mass Index and Carotid Intima-media Thickness in Autosomal Dominant Polycystic Kidney Disease.

The Relationship of Renalase with Diurnal Blood Pressure Rhythm, Left Ventricular Mass Index and Carotid Intima-media Thickness in Autosomal Dominant Polycystic Kidney Disease.

Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Published: December 23, 2025

Beyond the Watershed: Chronic Ischemic Colitis Masking Underlying Small Bowel Non-Hodgkin Lymphoma.

Beyond the Watershed: Chronic Ischemic Colitis Masking Underlying Small Bowel Non-Hodgkin Lymphoma.

Journal: Cureus
Published: December 19, 2025

Before the Pressure Rises: Intrarenal Renin-Angiotensin-Aldosterone System Activation in Normotensive Autosomal Dominant Polycystic Kidney Disease.

Before the Pressure Rises: Intrarenal Renin-Angiotensin-Aldosterone System Activation in Normotensive Autosomal Dominant Polycystic Kidney Disease.

Journal: Kidney360
Published: December 18, 2025

Perioperative Outcomes of Nephrectomy for Autosomal Dominant Polycystic Kidney Disease.

Perioperative Outcomes of Nephrectomy for Autosomal Dominant Polycystic Kidney Disease.

Journal: Urology practice
Published: December 17, 2025

Endoplasmic reticulum-mitochondrion disconnection promotes metabolic reprogramming and cystogenesis in polycystic kidney disease.

Endoplasmic reticulum-mitochondrion disconnection promotes metabolic reprogramming and cystogenesis in polycystic kidney disease.

Journal: bioRxiv : the preprint server for biology
Published: December 08, 2025

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of medicinal chemistry
Published: November 29, 2025
Showing 1-12 of 5,901

Last Updated: 02/24/2026